Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pre-clinical crawled time : 15:01 save search
Allogene Therapeutics Presents Preclinical Findings Supporting ALLO-605, the First Anti-BCMA TurboCAR™ T Cell Therapy, at the 62nd Meeting of the American Society of Hematology
Published: 2020-12-07 (Crawled : 15:01) - globenewswire.com
ALLO | $3.415 -1.3% 560K
|
Health Technology
|
| O: -0.09%
H: 0.09%
C: -13.56%
therapy t-cell preclinical pre-clinical
Kymera Therapeutics Presents Preclinical Data on IRAKIMiD and STAT3 Programs at Virtual 62nd American Society of Hematology (ASH) Annual Meeting
Published: 2020-12-07 (Crawled : 15:01) - globenewswire.com
KYMR | $34.38 -2.11% 190K
|
Health Technology
|
| O: 1.31%
H: 1.98%
C: -8.25%
preclinical pre-clinical
Allogene Therapeutics Presents Preclinical Data on ALLO-316 in Acute Myeloid Leukemia at the 62nd Meeting of the American Society of Hematology
Published: 2020-12-06 (Crawled : 15:01) - globenewswire.com
ALLO | $3.415 -1.3% 560K
|
Health Technology
| Email alert
Add to watchlist
leukemia myeloid leukemia preclinical pre-clinical acute myeloid leukemia
Editas Medicine Announces Preclinical Data and Large-Scale Manufacturing Process for EDIT-301, in Development for the Treatment of Sickle Cell Disease and Beta-Thalassemia
Published: 2020-12-05 (Crawled : 15:01) - globenewswire.com
EDIT | $5.355 -3.51% 1.2M
|
Health Technology
| Email alert
Add to watchlist
disease treatment preclinical pre-clinical
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.